期刊文献+

人CD154基因真核表达载体的构建及在Eca109细胞中的表达

Construction of eukaryotic expression vector pcDNA3.1-CD154 and its expression in Eca109 cell line
下载PDF
导出
摘要 目的:构建人CD154基因真核表达质粒pcDNA3.1-CD154,初步观察转染该质粒后Eca109细胞的细胞生物学特性。方法:人外周血单个核细胞体外经PHA激活后提取总RNA,用RT-PCR技术扩增人CD154cDNA全长并构建真核表达质粒pcDNA3.1-CD154。用LipofectamineTM2000介导pcDNA3.1-CD154质粒转染食管癌Eca109细胞株,RT-PCR检测转染细胞中CD154mRNA的表达,观察细胞生长特征。结果:用T7/SP6通用引物测序证实重组质粒中插入片段为正向插入的人CD154基因。pcDNA3.1-CD154转染Eca109细胞后细胞异型性明显改善,生长速率减慢。结论:pcDNA3.1-CD154构建成功;转染该质粒的Eca109细胞生物学特性发生改变。 Aim: To construct eukaryotic expression vector pcDNA3.1 GAAB2 CD154 and observe the biological characteristics of Eca109 cells transfected with the recombinant. Methods: Total RNA was extracted from peripheral blood mononuclear cells.The amplification of CD154 cDNA and the construction of PCDNA3.1 GAAB2 CD154 were conducted using RT GAAB2 PCR.Eca109 cell was transfected with PCDNA3.1 GAAB2 CD154,the expression of CD154 mRNA was detected using RT GAAB2 PCR. Results: The inserted sequence in the plasmid pcDNA3.1 GAAB2 CD154 was identfied with human CD154 cDNA sequence provided by GenBank (accession number: NM_000074). The growth velocity of the CD154 gene transfected Eca109 cells decreased and some biological characteristics of the cells altered. Conclusion: pcDNA3.1 GAAB2 CD154 is established successfully,and the characteristics of Eca109 cells have changed after transfecting with the vector.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2005年第4期581-583,共3页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省科技攻关基金资助项目0324410034 河南省科技创新人才工程项目20008402
关键词 CD154 真核表达载体 ECA109细胞 CD154 eukaryotic expression vector Eca109 cell line
  • 相关文献

参考文献9

  • 1Alexandroff AB, Jackson AM, Paterson T, et al. Role for CD40-CD40 ligand interactions in the immune response to solid tumours. Mol Immunol,2000,37 ( 9 ) :515
  • 2Schoenberger SP,Toes REM, van der Voort, et al. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature, 1998,393 ( 6 684) :480
  • 3Bennett SRM, Carbone FR, Karamalis F, et al. Help for cytotoxic-T-cell responses is mediated by CD40 signalling.Nature, 1998,393 (6 684) :478
  • 4Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immuno1,2002,23 ( 9 ) :445
  • 5Schmitz V, Barajas M, Wang L, et al. Adenovirus-mediated CD40 ligand gene therapy in a rat model of orthotopic hepatocellular carcinoma. Hepatology, 2001,34 ( 1 ) :72
  • 6Briones J, Timmerman J, Levy R. In vivo antitumor effect of CD40L-transduced tumor cells as a vaccine for B-cell lymphoma. Cancer Res,2002,62( 11 ) :3 195
  • 7Liu Y, Zhang X, Zhang W, et al. Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8 ( + ) cytotoxic T-cell activation and antitumor immunity. Cancer Gene Ther,2002,9(2) :202
  • 8Liu Y, Qureshi M, Xiang J. Antitumor immune responses derived from transgenic expression of CD40 ligand in myeloma cells. Cancer Biother Radiopharm ,2002,17 ( 1 ): 11
  • 9Wierda WG, Cantwell M J, Woods SJ, et al. CD40-1igand (CD154) gene therapy for chronic lymphocytic leukemia.Blood, 2000,96(9) :2 917

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部